加拿大癌症癌症选择列表:更新

IF 2 Q3 HEALTH POLICY & SERVICES Journal of Cancer Policy Pub Date : 2023-09-01 DOI:10.1016/j.jcpo.2023.100431
Safiya Karim , Corinne M. Doll , Brittany Dingley , Shaila J. Merchant , Fabio Ynoe de Moraes , Christopher M. Booth
{"title":"加拿大癌症癌症选择列表:更新","authors":"Safiya Karim ,&nbsp;Corinne M. Doll ,&nbsp;Brittany Dingley ,&nbsp;Shaila J. Merchant ,&nbsp;Fabio Ynoe de Moraes ,&nbsp;Christopher M. Booth","doi":"10.1016/j.jcpo.2023.100431","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Choosing Wisely (CW) Canada is a national campaign to identify unnecessary or harmful services that are frequently used in Canada. The original CW Oncology Canada Cancer list was developed in 2014. A CW Oncology Canada working group was established to review new evidence and guidelines and to update the current CW Oncology Canada Cancer List.</p></div><div><h3>Methods</h3><p>Between January and March 2022, we conducted a survey of members of the Canadian Association of Medical Oncology (CAMO), Canadian Association of Radiation Oncology (CARO) and the Canadian Society of Surgical Oncology (CSSO). We took the feedback from the survey, including potential new recommendations as well as those that were thought to be no longer relevant and up to date, and conducted a literature review with the assistance of the Canadian Agency for Drugs and Technology in Health (CADTH). The final updated list of recommendations was made by the CW Oncology Canada working group based on a consensus process.</p></div><div><h3>Results</h3><p>We reviewed two potential recommendations to add and two potential recommendations to remove from the existing CW Oncology Canada Cancer List. The recommendation “Do not prescribe whole brain radiation over stereotactic radiosurgery for patient with limited brain metastases (≤4 lesions)” was supported by several evidence-based guidelines with the strength of recommendations ranging from strong to moderate and the quality of evidence ranging from level 1 to level 3. After reviewing the evidence, the working group felt that the other potential recommendation to add and the two potential recommendations to remove did not have sufficient strength and quality of evidence at this time to be added or removed from the list.</p></div><div><h3>Conclusion</h3><p>The updated Choosing Wisely Oncology Canada Cancer List consists of 11 items that oncologists should question in the treatment of patients with cancer. This list can be used to design specific interventions to reduce low value care.</p></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"37 ","pages":"Article 100431"},"PeriodicalIF":2.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Choosing Wisely Oncology Canada Cancer List: An Update\",\"authors\":\"Safiya Karim ,&nbsp;Corinne M. Doll ,&nbsp;Brittany Dingley ,&nbsp;Shaila J. Merchant ,&nbsp;Fabio Ynoe de Moraes ,&nbsp;Christopher M. Booth\",\"doi\":\"10.1016/j.jcpo.2023.100431\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Choosing Wisely (CW) Canada is a national campaign to identify unnecessary or harmful services that are frequently used in Canada. The original CW Oncology Canada Cancer list was developed in 2014. A CW Oncology Canada working group was established to review new evidence and guidelines and to update the current CW Oncology Canada Cancer List.</p></div><div><h3>Methods</h3><p>Between January and March 2022, we conducted a survey of members of the Canadian Association of Medical Oncology (CAMO), Canadian Association of Radiation Oncology (CARO) and the Canadian Society of Surgical Oncology (CSSO). We took the feedback from the survey, including potential new recommendations as well as those that were thought to be no longer relevant and up to date, and conducted a literature review with the assistance of the Canadian Agency for Drugs and Technology in Health (CADTH). The final updated list of recommendations was made by the CW Oncology Canada working group based on a consensus process.</p></div><div><h3>Results</h3><p>We reviewed two potential recommendations to add and two potential recommendations to remove from the existing CW Oncology Canada Cancer List. The recommendation “Do not prescribe whole brain radiation over stereotactic radiosurgery for patient with limited brain metastases (≤4 lesions)” was supported by several evidence-based guidelines with the strength of recommendations ranging from strong to moderate and the quality of evidence ranging from level 1 to level 3. After reviewing the evidence, the working group felt that the other potential recommendation to add and the two potential recommendations to remove did not have sufficient strength and quality of evidence at this time to be added or removed from the list.</p></div><div><h3>Conclusion</h3><p>The updated Choosing Wisely Oncology Canada Cancer List consists of 11 items that oncologists should question in the treatment of patients with cancer. This list can be used to design specific interventions to reduce low value care.</p></div>\",\"PeriodicalId\":38212,\"journal\":{\"name\":\"Journal of Cancer Policy\",\"volume\":\"37 \",\"pages\":\"Article 100431\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer Policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213538323000486\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538323000486","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景加拿大明智选择(CW)是一项全国性的活动,旨在识别加拿大经常使用的不必要或有害的服务。2014年,加拿大癌症癌症协会(CW Oncology Canada Cancer)制定了最初的名单。加拿大癌症研究所成立了一个工作组,以审查新的证据和指南,并更新当前加拿大癌症癌症研究所列表。方法在2022年1月至3月期间,我们对加拿大医学肿瘤协会(CAMO)、加拿大放射肿瘤协会(CARO)和加拿大外科肿瘤学会(CSSO)的成员进行了调查。我们从调查中获得了反馈,包括潜在的新建议以及那些被认为不再相关和最新的建议,并在加拿大卫生药品和技术署(CADTH)的协助下进行了文献综述。加拿大癌症研究所工作组根据协商一致的程序提出了最终更新的建议清单。结果我们审查了从现有的加拿大癌症CW肿瘤列表中添加的两个潜在建议和删除的两个可能建议。“对于局限性脑转移(≤4个病灶)的患者,不要开全脑放射治疗而不是立体定向放射外科”的建议得到了几项循证指南的支持,建议的强度从强到中等不等,证据质量从1级到3级不等。在审查了证据后,工作组认为,另一项可能增加的建议和两项可能删除的建议目前没有足够的证据强度和质量,无法从名单中增加或删除。结论更新后的加拿大癌症选择明智肿瘤列表由11个项目组成,肿瘤学家在治疗癌症患者时应提出质疑。此列表可用于设计减少低价值护理的具体干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The Choosing Wisely Oncology Canada Cancer List: An Update

Background

Choosing Wisely (CW) Canada is a national campaign to identify unnecessary or harmful services that are frequently used in Canada. The original CW Oncology Canada Cancer list was developed in 2014. A CW Oncology Canada working group was established to review new evidence and guidelines and to update the current CW Oncology Canada Cancer List.

Methods

Between January and March 2022, we conducted a survey of members of the Canadian Association of Medical Oncology (CAMO), Canadian Association of Radiation Oncology (CARO) and the Canadian Society of Surgical Oncology (CSSO). We took the feedback from the survey, including potential new recommendations as well as those that were thought to be no longer relevant and up to date, and conducted a literature review with the assistance of the Canadian Agency for Drugs and Technology in Health (CADTH). The final updated list of recommendations was made by the CW Oncology Canada working group based on a consensus process.

Results

We reviewed two potential recommendations to add and two potential recommendations to remove from the existing CW Oncology Canada Cancer List. The recommendation “Do not prescribe whole brain radiation over stereotactic radiosurgery for patient with limited brain metastases (≤4 lesions)” was supported by several evidence-based guidelines with the strength of recommendations ranging from strong to moderate and the quality of evidence ranging from level 1 to level 3. After reviewing the evidence, the working group felt that the other potential recommendation to add and the two potential recommendations to remove did not have sufficient strength and quality of evidence at this time to be added or removed from the list.

Conclusion

The updated Choosing Wisely Oncology Canada Cancer List consists of 11 items that oncologists should question in the treatment of patients with cancer. This list can be used to design specific interventions to reduce low value care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
期刊最新文献
Corrigendum to "Cancer research funding in South Asia" [J. Cancer Policy 41 (2024) 100489]. Utilisation Patterns of Radiotherapy Among Older Patients: Insights from Portuguese National Cancer Registry Data. Time in the U.S. and colorectal cancer screening adherence among diverse immigrants Rapid diagnostic pathways for prostate cancer: A realist synthesis Overcoming barriers of cervical cancer elimination in India: A practice to policy level advocacy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1